miR-548a-3p Weakens the Tumorigenesis of Colon Cancer Through Targeting TPX2

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - August 26, 2020 Category: Cancer & Oncology Authors: Ming Wang Min Yang Benyuan Deng Source Type: research